Work

Safety and Early Data From a Phase Ii Trial of Pembrolizumab (pem) and Entinostat (ent) in Relapsed and Refractory (r/r) Hodgkin Lymphoma (hl) and Follicular Lymphoma (fl)

Year: 2019

Type: article

Study design: Clinical Trial

Source: Hematological Oncology

DOI: 10.1002/hon.143_2630

Authors: D. Sermer, S. Vardhana, C. Batlevi, A. Hamilton, A. Moskowitz, P. Caron, C. Moskowitz, M. Matasar, E. Biggar, E. Leung, J. Yahalom, J. Rademaker, A. Dogan, V. Seshan, A. Younes

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2951845155

FWCI:

Cites:

Cited by: 1

Related to: 10